Morrow Networks (MORR) reported today that a major hospital chain has revised its order for patient monitoring tools, shifting from a bulk purchase to a phased rollout. The change, which comes amid broader industry caution over supply chain delays, has led traders to reassess the company's near-term revenue outlook. While the move may slow short-term revenue growth, the adjustment aligns with a more measured approach to inventory management, a strategy some analysts view as prudent in the current climate. Investors are now watching for updates on the company's sales pipeline and how this shift affects its profit margins compared to rivals in the medical devices sector.